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ABSTRACT 
AL-AHMAD, SARA, F.M., Masters of Science: June : 2019, Biomedical Sciences 
Title: PROFILING the SALIVARY MICROBIOME in the QATARI POPULATION 
 
Supervisor ofThesis: Souhaila,  Al Khodor. 
           Humans are living ecosystems composed of human cells and microbes. The 
microbiome is the collection of microbes and their genes. Recent breakthrough in the 
high throughput sequencing technologies made it possible for us to understand the 
composition of the human microbiome. Launched by the National Institutes of Health 
in USA, the human microbiome project indicated that our bodies harbor a wide array 
of microbes, specific to each body site with inter and intra-personal variabilities. 
Numerous studies have indicated that, the microbiome composition plays an 
important role in health and disease, thus highlighting the significance of microbiome 
research in human health. 
 Saliva is a biofluid secreted from salivary glands composed of water, 
electrolytes, mucus, DNA, RNA, proteins, enzymes and microbes. Several studies 
assessed the role of the salivary microbiome in many conditions ranging from local 
diseases of the oral cavity such as dental carries and gingivitis to neurodevelopmental 
disease such as autism, indicating the potential of applying the knowledge generated 
from the salivary microbiome projects towards a better understanding of various 
pathological conditions.  
 In this study, we aim to profile the salivary microbiome of the Qatari population 
and identify the oral microbial communities in individuals with diabetes or obesity. 
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100 saliva samples collected from Qatari participants, selected randomly, were 
retrieved from Qatar Biobank repository. Samples were collected by spitting in a tube. 
After microbial DNA extraction, 16S rRNA gene was sequenced using Illumina 
Miseq.  Microbial profiles were then correlated with the individual phenotypic and 
clinical data to identify the microbial signatures associated with health and disease 
conditions, with special focus on diabetes and obesity due to the increasing prevalence 
rate of both conditions in Qatar.  
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CHAPTER 1: INTRODUCTION 
 The term microbiome refers to the collection of genomes annotated for all the 
microbes that form a habitat in a specific body site (Ursell, Metcalf, Parfrey, & Knight, 
2012). The other term that has been used extensively in the literature is Microbiota, 
which refers to the collection of the microbes themselves (Ursell et al., 2012). The 
advent in the molecular techniques especially sequencing methods, has made the study 
of the microbiome possible, since not all microbes are cultivable (Consortium, 2012a). 
 In an effort to introduce a profile of the human microbiota, the Human 
Microbiome Project (HMP) was initiated in 2008 with an aim to identify and 
characterize the core microbiota in humans using samples collected from different 
body sites (Peterson et al., 2009). The project achieved major milestones introducing 
3000 reference sets of genome sequences that represent microbial isolates from human 
samples (Peterson et al., 2009). This database is now used  as  a reference for 
researchers aiming to assess the microbiome composition in various study designs 
(Consortium, 2012a). The microbiome composition can be compared in health and 
disease (Althani et al., 2016), in longitudinal studies, microbial communities can be 
compared between seasons, between different subjects, or within the same subject but 
at different time periods (Cameron, Huws, Hegarty, Smith, & Mur, 2015).  
 Qatar Biobank (QBB) is an organization that aims to promote public health in 
Qatar by recruiting participants, collecting and storing a series of biological samples 
along with a comprehensive assessment of the individual phenotypic, dietary and 
clinical data among others. Saliva samples used in this study were collected from 
participants recruited in QBB (discussed in more details in the chapter 3: Materials 
and Methods) for the purpose of investigating the salivary microbiome. 
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 In this study, we aim to profile the salivary microbiome of the Qatari population 
and identify the oral microbial communities in individuals with diabetes or obesity. A 
total of 100 saliva samples randomly selected from the QBB participants, were 
obtained for microbial profiling. The microbiome profiles of the 100 saliva samples 
were correlated with the clinical data and phenotypic data, in order to identify 
microbial signatures associated with various diseases or pathological conditions.  In 
this project, we focused on diabetes and obesity due to their increasing prevalence rate 
in Qatar.  
 
HYPOTHESIS: 
 In this study, we hypothesize that saliva samples have a microbial composition 
that vary between individuals, and that specific microbial signatures can be associated 
with various pathological conditions and diseases.  
To test this hypothesis, we aim to: 
1. Study the microbiome composition of 100 saliva samples collected from 
Qatari participants in QBB. 
2. Correlate the microbial composition with the clinical data in order to identify 
specific signatures associated with various pathological conditions. 
3. Identify salivary microbial communities associated with diabetes and obesity. 
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 CHAPTER 2: REVIEW OF THE LITERATURE 
 
1. The human microbiome project 
 The human microbiome has gained a considerable attention especially after the 
initiation of the HMP (Turnbaugh et al., 2007). In order to characterize the normal 
microbiota of different body habitats in healthy adults, an extensive sampling was 
planned across two time points. (Consortium, 2012b). The HMP recruited 242 
volunteers (129 males, 113 females) and sampled tissues from 15 body sites in men 
and 18 body sites in women (Huttenhower et al., 2012). By incorporating several 
complementary techniques and analyses including 16S ribosomal RNA (rRNA) gene 
sequencing, whole-genome shotgun sequencing (WGS) and aligning the assembled 
sequences to the reference microbial genomes they were able to define the 
microbiome composition of each body site they sampled from (Huttenhower et al., 
2012). Several studies has been conducted afterward in order to characterize the core 
microbiome that make up a status of symbiosis or in other words “microbiome in 
health” (Lloyd-Price et al., 2017). A healthy individual maintains a unique balance 
between the microbiome, immune system for protection from invading bacteria 
(Belkaid & Hand, 2014). However, in some cases pathogenic bacteria increases in 
numbers replacing the beneficial bacteria (microbial dysbiosis) leading to a significant 
impact on our health (Carding, Verbeke, Vipond, Corfe, & Owen, 2015).  
 
 
2. Development of the microbiome: Inception from the early days of life 
 The process of microbiome colonization starts early in life even before birth 
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(Mueller, Bakacs, Combellick, Grigoryan, & Dominguez-Bello, 2015). The microbial 
contact during prenatal life and the inoculum transferred during birth and 
breastfeeding imprint the infant’s microbiota and the immune system. 
  The mode of birth was shown to play an important role in the composition of 
the microbiome in the early days of life as babies born through a cesarean section 
carry a different microbiome as compared to those who were born naturally 
(Francavilla, Cristofori, Tripaldi, & Indrio, 2018). Moreover, the mode of feeding the 
neonates was also shown to play an important role in the seeding of their gut 
microbiome, as  babies who were strictly breastfed had a different gut microbiome 
composition as compared to those who were mixed fed with formula milk (Backhed 
et al., 2015). By the end of the second year of age, the taxonomic composition of the 
gut microbiome stabilizes and converges towards a characteristic adult gut 
microbiome. 
 
 
3. The salivary microbiome 
 Saliva is produced by multiple salivary glands, the major glands (major is 
referred to their size) which are the parotid glands and the submandibular gland 
(Humphrey & Williamson, 2001). The major glands accounts for 90% of salivary 
secretion (de Paula et al., 2017). The minor glands which are found in the tongue, 
cheeks and lower lip account for 10% of  the produced saliva, these glands are 
responsible for the production of  serous saliva (de Paula et al., 2017). The average 
amount normally produced by humans ranges from 1 to 1.5 liters of saliva daily 
(Humphrey & Williamson, 2001). 
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 Saliva contains several components such as electrolytes, proteins, 
immunoglobulins, enzymes and microbes (Humphrey & Williamson, 2001). 
Electrolytes together with proteins for examples maintain the process of 
mineralization and remineralization (Humphrey & Williamson, 2001). 
Immunoglobulins help in the neutralization of harmful pathogens without eliciting an 
inflammation. Urea, bicarbonate and phosphatase maintain a steady salivary pH of 6 
to 7 (Humphrey & Williamson, 2001).  
 One of the major components that promote the colonization of bacteria and 
fungi is mucin (Humphrey & Williamson, 2001). Mucins are non-immunologic 
glycosylated proteins that also act as lubricants, and provide protection from acid 
penetration to the cells by forming a barrier (Humphrey & Williamson, 2001). Being 
highly available, saliva is considered as an easy to collect sample that does not require 
hospitalization or special preparation (Kaczor-Urbanowicz et al., 2017).  
 Salivary microbiome is temporally stable as it does not fluctuate according to 
the circadian rhythm (Belstrøm et al., 2016). Collection of saliva can be achieved by 
several methods including spitting, swabbing, and the draining method (Priya & 
Prathibha, 2017). The method of collection exert a minimal effect on  the extraction 
of microbial DNA (Y. Lim, Totsika, Morrison, & Punyadeera, 2017).  
 The healthy adult human mouth hosts a complex and resilient ecosystem of 
hundreds of different microbial species (Rosier, Marsh, & Mira, 2018). These 
microbes reside in different sites of the oral cavity, which is mainly composed of a 
soft mucosa that is constantly shedding, and the hard surface which comprises the 
teeth (He, Li, Cao, Xue, & Zhou, 2015). The saliva is a representing constituent of 
both locations but more profoundly the soft mucosa (He et al., 2015). According to 
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many studies, the most predominant phyla of the salivary microbiome are Firmicutes, 
Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacteria (Ahn et al., 
2011;(Zhou et al., 2016)). 
 Located at the opening of the gastrointestinal tract, the oral cavity provides a 
convenient, accessible site for collecting and analyzing microbial samples in the saliva 
(Kodukula et al., 2017). It is also worth noting that, the salivary microbiome mirrors 
the gut microbiome in terms of complexity and diversity (Kodukula et al., 2017). 
 
 
4. The gut microbiome 
 The gut microbiome had been studied extensively for many reasons such as the 
immense populations of microbiota residing at this site,  the easiness of obtaining the 
fecal matter as a representative of the microbiota of that site (Lynch & Pedersen, 
2016). It is estimated that the number of gut microbiota may be more than 1014 and 
the genomic content of the microbiota is 100 times more than the human genome 
(Thursby & Juge, 2017). The gut microbiome was described as part of the MetaHIT 
cohorts and indicated that a large proportion of the microbial genes are shared between 
individuals of this cohort, and more than 99% of these genes are bacterial; 
representing 1000 to 1150 bacterial species(Dusko Ehrlich, 2010). A healthy gut has 
mainly  five  phyla which is mainly composed of strict anaerobes and  dominated by 
2 main phyla: Bacteroidetes and Firmicutes(Rinninella et al., 2019).  
 
5. Factors that affect the salivary microbiome composition 
 Several pre and post-natal factors can significantly alter the composition of the 
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salivary microbiome including host genetics, the mode of delivery at birth; the method 
of infant feeding; teeth eruption, the use of medications, especially antibiotics; 
smoking, oral hygiene and diet among others. 
 The salivary microbiome in neonates was shown to be different in breast-fed or 
formula fed babies (Al-Shehri et al., 2016). The study had shown that there is a higher 
prevalence of Bacteroidetes in the mouths of formula-fed infants when compared to 
breast-fed infants, but in contrast Actinobacteria were more prevalent in breast-fed 
babies and  Proteobacteria was more prevalent in the saliva of breast-fed babies when 
compared to the than in formula-fed neonates (Al-Shehri et al., 2016).  
 Moreover, the Human Oral Microbe Identification Microarray (HOMIM) was 
used to compare the oral microbiome of babies who were born via c-section versus 
those who were born naturally, and  found the later has a greater number of taxa (Lif 
Holgerson, Harnevik, Hernell, Tanner, & Johansson, 2011). The newborn oral cavity 
initial colonizers are Streptococcus salivarius, since it  has the ability to adhere to the 
epithelial surfaces and produce polymers that facilitate the adherence of other bacteria 
including Actinomyces sp (Sampaio-Maia & Monteiro-Silva, 2014).  
 When eruption of teeth starts, the colonization of Streptococcus mutans begins, 
which is considered a cariogenic Streptococcus sp due their preference on colonizing 
hard tissue such as teeth (Sampaio-Maia & Monteiro-Silva, 2014). Although, it was 
also found that S. mutans are also present in edentulous infants (Cephas et al., 2011). 
 The major role that the diet plays in modulating the microbiome composition, 
promoted the potential for interventional studies using diet or dietary products to alter 
and improve the microbiome composition especially the gut microbiome in order to 
improve health (Wen & Duffy, 2017). A recent longitudinal study examined the effect 
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of the consumption of yogurt rich with probiotic versus using a standard yogurt on the 
composition of the salivary microbiome,  an increase in the alpha diversity after a 
short term consumption of probiotics was observed (Dassi et al., 2018).  
 While genetics was shown to play a role in the microbiome composition 
(Julia K. Goodrich et al., 2014),  a  microbiome study conducted for Ashkenazi Jewish 
population by analyzing the salivary microbiome for  pedigrees of families, concluded 
that the environment and shared household, plays a greater role in shaping the 
microbiome composition when compared to genetics (Shaw et al., 2017). While 
multifactorial, it is clear that the  environment and  host genetics together are major 
modulators of the microbiome composition (M. Y. Lim et al., 2014). 
 The use of broad-spectrum antibiotics has negative effects on the composition 
of the gut microbiota, which results in significant drops in taxonomic richness, 
diversity and evenness of the gut microbial communities (Thiemann, Smit, & Strowig, 
2016). Another study has concluded that individuals exposed to a single antibiotic 
treatment, undergo considerable microbial shifts and enrichment in antibiotic 
resistance in their gut microbiome composition, while their salivary microbiome 
composition remains unexpectedly stable (Zaura et al., 2015). On the other hand, it 
was shown that children receiving antibiotics treatment for otitis media infection have 
a microbial shift in their salivary microbiome that was recovered three weeks after the 
treatment ended (Lazarevic et al., 2013).  
5.1. Oral hygiene 
 Saliva flow along with good hygienic practices both aid in the detachment of 
biofilms that are known to cause proliferation of pathogenic species (Zarco, Vess, & 
Ginsburg, 2012). Moreover as a result of poor hygiene, acid-byproduct as a result of 
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sugar or carbohydrate product may aid in the formation of caries (Yadav & Prakash, 
2016).  A study demonstrated the role of poor oral hygiene status in children in 
association to salivary microbiome composition, found an increase 
of Veillonella species (Mashima et al., 2017).  
 
 
5.2. Smoking 
 
     In a large American cohort study, J. Wu et al  compared the salivary microbiome 
composition in both current smokers and non-smokers (J. Wu et al., 2016). They ob- 
served that the salivary microbiome of smokers reflected  a decrease in the abundan- 
ce of the phylum Proteobacteria, and in Capnocytophaga , Peptostreptococcu-  
s and Leptotrichia genera; while the genera Atopobium and Streptococcus were 
found to be elevated in smokers compared to non-smokers (J. Wu et al., 2016). 
Another study examined the oral microbiome of smokers and non-smoker in addition 
to the cytokine levels, where they found that smoking altered the cytokine levels and 
the salivary microbiome composition (Rodríguez-Rabassa et al., 2018). 
 
 
6. Microbiome in disease: Microbial dysbiosis  
 A healthy individual maintains a unique balance between the microbiome, 
immune system for protection from invading bacteria (H.-J. Wu & Wu, 2012). 
Dysbiosis refers to the disturbance in the composition of microbiota at a particular site 
(Petersen & Round, 2014). Dysbiosis in gut microbiome for example, has been linked 
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to several diseases and conditions such as Crohn’s disease and irritable bowel 
syndrome (Frank et al., 2007; Ni, Wu, Albenberg, & Tomov, 2017). Another example 
of dysbiosis is bacterial vaginosis caused by dysbiosis of the vaginal microbiota which 
usually triggered by G. vaginalis (Younes et al., 2018). 
 Dysbiosis of the oral microbiome has been implicated in various oral diseases 
such as periodontitis where it promotes pathogenic bacterial growth and enables the 
dissemination of the oral bacteria systemically (Li, Kolltveit, Tronstad, & Olsen, 
2000).  
Many studies were conducted in order to assess the dental and periodontal health in 
association with the microbiome composition: In a study that compared caries free 
individuals versus caries experienced individuals, they found that caries free 
individuals had a greater microbial diversity (Yasunaga et al., 2017). Similar finding 
was also observed by other studies that showed that healthy individuals have a greater 
microbial diversity and a greater abundance of Neisseria, Haemophilus, and 
Fusobacterium, in contrast to those who have dental caries where Streptococcus was 
the most abundant genus detected (Belstrøm et al., 2017). 
 Moreover, the oral microbiome dysbiosis have been associated with systemic 
diseases including obesity, diabetes, cancer, rheumatoid arthritis, Parkinson's 
disease  and cardiovascular diseases among others (Acharya et al., 2017; Karpiński, 
2019; Pereira et al., 2017; X. Zhang et al., 2015).  
 A recent study by Janem et al  indicated that higher rates of  type 2 diabetes 
(T2D)  were observed in kids with improper oral health in comparison with lean and 
obese children without diabetes (Janem et al., 2017). The authors indicated that 
Fretibacterium was only found in the diabetic group but Alloprevotella, Haemophilus, 
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Lautropia  and  Pseudomonas were decreased in the diabetic group in comparison to 
healthy controls (Janem et al., 2017). A Thai study also support the previous in  which 
the acid-tolerant bacteria, which are also associated with dental caries, are found more 
prevalent in T2D patients (Kampoo, Teanpaisan, Ledder, & McBain, 2014). 
Moreover, the salivary microbiome composition differs in people who are obese 
compared to the lean controls, the study also proposed that  such microbial  differences 
can help predict the susceptibility of people with obesity to T2D o(Y. Wu, Chi, Zhang, 
Chen, & Deng, 2018).  
 
7. Tools used to assess the microbiome composition: 16S rRNA gene sequencing  
 The ribosomal RNA transcriptional machinery is an essential component of 
life(Wang & Qian, 2009). Thus, the gene that represents it has a conservative nature 
which led to an enormous opportunity for the exploration of many microbial 
communities by sequencing specific hypervariable regions of the 16S rRNA gene 
(Wang & Qian, 2009). Amplicons are generated using universal primers used to 
anneal with the conserved regions of the 16S rRNA gene sequences (Wang & Qian, 
2009). Those hypervariable region sequences are highly polymorphic, therefore, 
allowing the classification of the bacterial taxa from phyla to species levels (Cox, 
Cookson, & Moffatt, 2013). The resulting sequencing data is then aligned to the 16S 
rRNA reference database to yield the operational taxonomy units (OTUs) of bacteria 
(Nguyen, Warnow, Pop, & White, 2016). Despite being efficient and relatively cheap, 
the 16S rRNA sequencing has its limitations, as it only covers microbiota of the 
bacterial kingdom, thus neglecting other important microbes belonging to Fungi, 
viruses and others, in addition to biases generated due to the variability of the 16S 
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gene copy number in different bacteria (Liu, Gibbons, Ghodsi, Treangen, & Pop, 
2011).  
 The shotgun sequencing as the name infers, is the process of fragmenting the 
whole genome into short oligonucleotide bases followed by sequencing and assembly 
of the contigs (Jovel et al., 2016). This method allows a greater depth of sequencing 
data in comparison to the 16S sequencing approach discussed previously (Vincent et 
al., 2016). The shotgun sequencing provides information about the taxonomic profile, 
functional composition and gene abundance of the microbiota (Quince, Walker, 
Simpson, Loman, & Segata, 2017). It can also provide information up to species/strain 
level compared to 16S rRNA gene sequencing (Quince et al., 2017). The major 
disadvantages of the shotgun sequencing is the huge amount of data it generates, 
which requires a high-throughput sequencing instruments and thus a higher cost 
(Franzosa et al., 2015). 
 
 
8. Aims of the project 
The aim of this project is to profile the salivary microbiome of 100 saliva samples 
collected from Qatari participants and correlate the microbial composition with the 
clinical data in order to identify specific signatures associated with various 
pathological conditions with a focus on diabetes and obesity being the most prevalent 
non-communicable diseases and pathological conditions in Qatar.  
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CHAPTER 3: METHODOLOGY 
The layout of the Methods used in this study in Figure 1. 
 
 
Figure 1:Summerized  method workflow 
1. Description of the study participants 
 A total of 100 participants were randomly selected from QBB, and included 
both females and males. Using the body mass index (BMI), samples were categorized 
in normal weight (BMI 18.5 to 24.9 kg/m2), overweight: (BMI  25 to 29.9 kg/m2) and 
obese (BMI is 30 kg/m2 or more). Also, the study subjects were stratified into normal 
and diabetic according to their HbA1C levels (diabetic: HbA1c ≥6.5% (48 
mmol/mol) ).  
 
2. Inclusion/ Exclusion criteria 
 The samples were collected by QBB from Qatari subjects participating in the 
Qatar Genome Project, who were eighteen years old and above. No exclusion criteria 
Sample collection
DNA extraction
PCR
PCR products purification
Sequencing
Data analysis
correlation
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were used in the subject’s selection. 
 
3. Sample collection  
 In this project, an agreement between QBB and Sidra Medicine was signed in 
order to collect de-identified salivary samples, phenotypic and clinical data from a 
total of 100 participants that were selected randomly.  
 Salivary samples were collected after obtaining the IRB (Institutional Review 
board) approval from QBB (E/2017/RES-ACC-0046/0003) and Sidra 
(IRB#1510001907). Samples were stored at – 80oC. Before processing, samples were 
kept at 4oC overnight.  The first step before extraction was to incubate the salivary 
samples at 50oC for 2 hours. 
 
4. DNA extraction from saliva using QIAsymphony 
 Automated extraction following Qiagen QIAsymphony protocol was carried on 
following the manufacturer’s instructions. Briefly, the procedure is composed of four 
steps including lysis, binding, washing, and elution.  As illustrated in Figure 1, the 
instrument utilizes binding of magnetic beads to the genomic DNA which is then later 
bound to a mechanical magnetic rod. One of the biggest advantages of the magnetic-
particle technology is the isolation of quality DNA without impurities. 
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Figure 2: Schematic representation of the QIAsymphony SP protocol used for DNA 
extraction 
 
 
Step 1: Lysis 
Reagent 1 is added to the sample which causes lysis to the cell and release of the 
genomic DNA, then the magnetic beads are added to bind to genomic DNA. 
Step 2: binding 
The magnetic rod is inserted into the well holding the sample and this attracts the 
magnetic beads. 
Step 3: washing 
The magnetic rod is inserted into another well, and the magnetic beads are released. 
Step 4: Elution 
Another reagent is added to elute the genomic DNA from the magnetic beads. Then 
the magnetic rod will attract the remaining magnetic beads leaving the eluted volume 
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in the DNA stock solution. 
5. DNA Quality control 
 The quality and quantity of the extracted DNA was checked using nanodrop 
(Thermo Scientific). The Nanodrop utilizes the concept of spectrophotometry that 
uses absorbance as a measurement of nucleic acid concentration.  
 
6. Amplification of 16S rRNA gene fragment by polymerase chain reaction 
  Polymerase chain reaction (PCR) of the 16S rRNA gene was carried on 
for each sample. The designed 27-F forward primers are linked to a specific sequence 
that is used as a barcode to distinguish each sample for the sake of multiplexing in 
downstream procedures. The primers are also designed to align with the conserved 
region of the 16S rRNA gene (Figure 2). The reverse primer, which also align with a 
conserved region, was common across all sample’s reactions. In this study, the 
targeted region as shown in Figure 2 is the V1 until V3 region which yield an amplicon 
size of 610 base pairs. 
 
 
 
Figure 3: 16S rRNA gene: the red boxes represent the variable regions, whereas the blue 
areas in between the boxes represents the conserved region. 
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Table 1 
The sequence of the forward and reverse primers to target V1V3 region of 16S rRNA 
gene 
Prime
r 
Illumina adaptors Barcode Forward Primer 
Pad 
Link
er 
Forward 
primer 
sequence 
27F1 AATGATACGGCGACC
ACCGAGATCTACACGC
T 
AGCCTT
CGTCGC 
TATGGTAATT GT AGAGTTTG
ATCMTGG
CTCAG 
534-R 
 
CAAGCAGAAGACGGC
ATACGAGAT 
 
- 
 
AGTCAGCCAG 
 
CC 
 
ATTACCGC
GGCTGCTG
G 
 
 
Table 2 
PCR reaction mix 
# Reagent Volume 
1 PCR gradient, water  adjusted for each sample to reach a 
reaction volume of 50 µl 
2 Phusion Master Mix catalogue #f531L 25 µl 
3 27-F1 primer (F1-F96) 1 µl 
4 534-R primer 1 µl 
5 Samples DNA Adjusted with water to reach 10 ng/ 
µl 
Total volume 50 µl 
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To set-up the PCR reaction each sample template concentration was adjusted with 
water to reach the optimum concentration of 10ng/50uL reaction. The forward primer 
that is designated for each sample was then added. Then followed by addition of the 
reverse primer and the master mix. The master mix is a readymade (cat# F531L) that 
includes all the essential PCR components such as dNTPs, DNA polymerase enzyme, 
Buffer, and MgCl2. . The final volume of the PCR reaction is 50 µl. 
 
7. PCR thermal conditions and duration 
 The thermal cycling conditions used to amplify the 16S rRNA gene were set  as  
following: 5 min of initial denaturation at 94 °C; 30 cycles of denaturation at 94 °C 
for 30 s, annealing at 62 °C for 30 s, and elongation at 72 °C for 30. Finally, after the 
30 cycles at 72 °C the samples were incubated for additional 10 minutes. 
 
8. Gel electrophoresis 
 The quality of the amplified PCR products was assessed using 2% agarose gel 
electrophoresis. 100 bp DNA ladder (Thermo Scientific) was used to check the size 
of the product.  
 Once the libraries of each sample were constructed, the samples were pooled in 
one tube. Since each sample has a unique sequence barcode, the sequencing analyzer 
can read and demultiplex each sample in a separate FASTAQ file. The optimum 
volume of each sample to be pooled is 5uL (Intense band), 10uL (Moderate band), 
15uL (Faint band).  
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9. 16S library magnetic bead purification  
 This step (Figure 3) employs the use of magnetic beads that is combined with a 
carboxyl molecule that allows the separation of negatively charged DNA. This  
technique  is termed solid phase reversible immobilization or SPRI (Hawkins, 
O'Connor-Morin, Roy, & Santillan, 1994). There are many advantages for this 
technique: easy to perform as  it does not require centrifugation nor filtration and that 
it does favor the isolation of PCR products over excess primers or genomics DNA.  
 
 
 
Figure 4: AMPure XP magnetic beads purification of the PCR product 
 
 
10. AmpPure magnetic bead purification  
We followed the procedure below:  
1. Add 100 µl of PCR pool to 112 µl of Ampure beads. 
2. Mix the solution thoroughly by pipetting up and down for 10 times. 
3. Incubate the solution for 2 minutes at room temperature on the magnetic stand. 
4. Discard the supernatant. 
5. Add 200 µl of 80% freshly prepared ethanol. 
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6. Incubate the solution for 30 seconds at room temperature on the magnetic 
stand. 
7. Discard the supernatant. 
8. Repeat step 5-7  one more time. 
9. Allow to air dry for 10 minutes. 
10. Elute with 55 µl 10 mM Tris pH 8.5. 
 
11. Assessment of the PCR product quality using Agilent bioanalyzer and Qubit 
fluorometer 
11.1. Agilent High sensitivity kit 
 The High sensitivity DNA kit was used to assess the quality of the PCR 
constructed libraries. The Agilent bioanalyzer uses the concept of small capillary 
electrophoresis. The samples were run against a ladder and a marker. To start up the 
run, the following procedure was performed: 
1. The High Sensitivity DNA dye concentrate (blue) and High Sensitivity DNA 
gel matrix (red) has to reach room temperature for 30 minutes before 
proceeding. 
2. The blue vial with High Sensitivity DNA dye concentrate has to be vortexed 
for 10 seconds followed by centrifugation or spin down.  
3. Pipette 15 µl of the blue dye concentrate (blue) into a High Sensitivity DNA 
gel matrix vial (red). Store the dye concentrate at 4 °C in the dark again. 
4. Take the entire gel- dye mix to the top part of the spin filter.  
5. Centrifuge the spin filter for 10 minutes at 6000 rpm at room temperature.  
6. Discard the filter and label the tube with the preparation date. 
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7. Loading the Gel-Dye mix:  place a new High Sensitivity DNA chip on priming 
station. Pipette 9.0 µl of the gel-mix at the well-labled. 
8. Loading the marker: dispense 5 µL of green- High Sensitivity DNA marker 
(green) into the well labeled with the ladder figure and also into all sample 
wells. 
9. Dispense 1 µl of the High Sensitivity DNA ladder vial (yellow) in the well-
labeled with the ladder figure. In each of the 11 sample wells, dispense 1 µl of 
sample  or 1 µL of marker for the unused wells. 
10. Start the Chip Run.  
 
11.2. Qubit Fluorometer 
 
 The Qubit™ 4 Fluorometer is a benchtop fluorometer that can be used for the 
quantitation of DNA. The measurement of the fluorescence in samples reflect the 
concentration of DNA. In this study, Qubit™ 4 Fluorometer was used to measure the 
concentration of the constructed libraries before proceeding to sequencing in order to 
ensure the optimal concentration needed for sequencing. 
 
12. Sequencing 
 In order to sequence the constructed libraries, the Illumina Miseq platform was 
used in this study. The principle that Illumina follows is sequencing by synthesis and 
reversible termination. This principle is based on the addition of fluorescently labeled 
dNTPs that are reversible terminators. All the added terminator bases are added at the 
same time; thus, less competition of incorporation is seen. According to Illumina 
MiSeq protocol, the Illumina sequencing workflow is composed mainly of four steps: 
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samples preparation, cluster generation, sequencing and data analysis. 
Sample preparation: the libraries are customized as mentioned in the PCR step above. 
Each forward primer is designed with a unique barcode and an illumina compatible 
adaptor. In addition, the reverse strands are also linked with illumina compatible 
adaptors. 
Cluster generation: the flow cell contains oligo adaptors that are complementary to 
the adaptors of the library fragments. The pooled libraries are loaded to the flow cell. 
When hybridization of the forward strand with the flow cell adaptor occurs, the 
reverse strand is then synthesized. Next, when the forward strand is washed away, the 
reverse strand folds hybridizing to the neighboring adaptor. Then, a bridge 
amplification by the DNA polymerase follows. This process forms the clusters that 
will be later sequenced. 
Sequencing: The four fluorescently labeled nucleotide are added at the same time in 
which they compete to bind to the template attached to the flow cell. The added 
nucleotide are called reversible terminators since they are blocked for further reaction 
at the 3-OH end (Ambardar, Gupta, Trakroo, Lal, & Vakhlu, 2016). The instrument 
captures the fluorescence of the designated base and records the read. After the 
cleavage of the terminating moiety and the fluorophore molecule, another cycle begins 
again. This cycle is repeated 300 times for the read 1 and the same number of cycles 
for read 2.  Figure 4 illustrates the sequencing workflow step by step. 
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13. Sequencing Procedure 
 Before loading the purified pooled libraries, dilution and denaturation following 
the protocol provided by Illumina (document # 15052877) should be followed. In the 
case of using customized primers, the primers also should be added to the reagent 
cartridge. 
Sequencing was performed using MiSeq Reagent Kit v3 600 cycle kit which consists 
of a reagent cartridge, flow cell and PR2 reagent. The MiSeq System Guide for Local 
Run Manager (15027617 v04) illustrate the full procedure in setting up the instrument 
and loading the reagent cartridge. The procedure was performed according to the 
manufacturer’s instruction and recommendations. 
 
 
Figure 5: Sequencing by synthesis, Source:(Mardis, 2013) 
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14. Data Analysis 
 Sequenced data were demultiplexed using MiSeq Control Software (MCS) in 
MiSeq (Illumina) sequencer. Generated demultiplexed data were revised for quality 
control using FastQC (Andrews S, 2012). Forward and reverse end sequences of 
respective samples were merged through PEAR tool (J. Zhang, Kobert, Flouri, & 
Stamatakis, 2014)) and sequence reads of quality score < 30 were discarded. All 
merged reads were trimmed to 160bp>Reads<500bp using Trimmomatic tool (Bolger, 
Lohse, & Usadel, 2014). Trimmed FASTQ files were converted into FASTA files. 
Demultiplexed FASTA files were analyzed using QIIME software v1.9.0 pipeline 
(Caporaso et al., 2010). QIIME is a an open-source software which analyzes raw data 
as an input to generate output data in the desired format. such as OTUs (Kuczynski et 
al., 2011) by aligning against the Human Oral Microbiome Database or  HOMD 
(Escapa et al., 2018). Alpha diversity was calculated using phyloseq package in R 
platform  (McMurdie & Holmes, 2013). Beta diversity was calculated using Unifrac 
distance method for all microbial communities of the sample through principal 
coordinates analysis (Chang, Luan, & Sun, 2011). Association between clinical 
metadata and salivary microbiome data were done using Hierarchical All-against-All 
significance testing or abbreviated HAllA (Gholamali Rahnavard). In order to assess 
the microbial changes  that were statistically significant, LefSe analysis ( linear 
discriminant analysis of effect size) was used (Segata et al., 2011). The predictive 
functional profiling of microbial communities in association with BMI categories and 
diabetic versus non-diabetic categories was analyzed using PiCrust (Langille et al., 
2013). 
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CHAPTER 4: RESULTS 
 
1. Description of the study participants 
 
 
Table 3 
Demographic data of Studied Qatari Population 
 
FEMALE MALE Total 
AGE 40.63±11.44 38.76±10.04 
 
GENDER 48 52 100 
 
BMI 
   
Normal 11 (22.92%) 11 (21.15%) 22 
Overweight 14 (29.17%) 18 (34.62%) 32 
Obese 23 (47.91%) 23 (44.23%) 46 
 
Diabetes 
   
Non-Diabetic 34 (70.8%) 37 (71.15%) 71 
Diabetic 14 (29.2%) 15 (28.85%) 29 
    
    
    
Note-Age - Average ± Standard deviation 
 
  
26 
 
 
 
2. Microbial DNA Quality and Quantity 
 The quality and quantity of DNA were measured using spectrophotometery. 
The optimal amount of DNA needed for PCR is 10 ng . The absorbance ratio  of 
A260/A280 of 1.7–2.0 is the optimum in terms of DNA quality. 
 
3. PCR product visualization using agarose gel electrophoresis 
 PCR product from each sample was checked against a ladder using 2% agarose 
gel electrophoresis. Figure 5 is an example of amplified PCR libraries used for 
sequencing.  
 
Figure 6: Gel electrophoresis for PCR products 
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4. Taxa summary  
 Characterization of the relative abundance of salivary microbiome at the 
phylum level in saliva samples collected from normal, overweight and obese Qatari 
participants revealed that Bacteroidetes, Firmicutes and Proteobacteria were the most 
common phyla detected (Figure 6). The results showed that Firmicutes was higher in 
normal subjects (35.4%) compared to overweight (25%) and obese (29.3%) 
participants.  
 
Figure 7: Relative abundance of bacterial phyla among salivary samples 
 
 
On the other hand, Bacteroidetes was higher in overweight (52.8%) and obese subjects 
(52.8%) when compared to normal weight participants (45.8%) (Figure 7). 
Abundance of Proteobacteria was slightly higher in normal weight (6.6%) than 
overweight (5.3%) and obese (5.2%) participants (Figure 7).  
 The relative abundance of salivary microbiome at phylum level between normal  
(non-diabetic) and diabetic group revealed that Firmicutes was higher in the diabetic 
group (33.3%) compared to the normal (non-diabetic) group (28.1%). On the other 
hand, Bacteroidetes was elevated in the normal group (52.3%) than diabetic group 
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(48%) (Figure 8). Proteobacteria was higher in the normal group (5.8%) compared to 
the diabetic group (4.7%). Fusobacteria, Saccharibacteria, Abscondibacteria and 
Actinobacteria were the least abundant phyla (Figure 8). Although there were many 
differences in the relative abundance at both the phyla level and genus level, statistical 
analyses using Kruskal Wallis test did not detect any significant differences (p 
value>0.05). 
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Figure 8: Comparison of the microbial taxa at the phylum level in normal weight, overweight 
and obese 
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Figure 9: Taxa summary of the phylum level for Diabetic Versus Normal 
 
 
5. Relative abundance of the salivary microbiome at the Genus level  
 Characterization of the relative abundance of the salivary microbiome at genus 
level in saliva samples collected from normal, overweight and obese Qatari 
participants revealed that Prevotella sp., Streptococcus sp., Veillonella sp., and 
Porphyromonas were the most abundant genera (Figure 9). The results showed that 
Streptococcus sp., was higher in the normal group (19%) compared to the overweight 
(9.9%) and obese (13.2%) participants. Likewise, Porphyromonas sp., was higher in 
normal (11.8%) compared to the overweight (7.5%) and obese participants (7.5%). 
On the other hand, Prevotella sp., was higher in overweight (42.8%) and obese 
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(42.8%) compared to the normal weight participants (30.9%) (Figure 9). Abundance 
of Veillonella sp. was slightly higher in obese (11.8%) compared to overweight 
(10.9%) and normal weight participants (11.2%) (Figure 9).  
 The relative abundance of salivary microbiome at genus level between normal 
and diabetic group revealed that Streptococcus sp was slightly higher in the diabetic 
group (15%) compared to the normal group (13%). On the other hand, Prevotella sp., 
was elevated in the normal group (41.5%) than diabetic group (36.5%) (Figure 10). 
Although there were many differences in the relative abundance at both the phyla level 
and genus level, statistical analyses using Kruskal Wallis test did not detect any 
significant differences (p value>0.05). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Normal Overweight obese 
g__Porphyromonas  11.8% 7.5% 7.5% 
g__Prevotella 30.9% 42.8% 42.8% 
g__Streptococcus 19.0% 9.9% 13.2% 
g__Veillonella 11.2% 10.9% 11.8% 
Figure 10: Taxa summary of the genus level for BMI categories with most abundant genera 
g: Porphyromonas 
g: Prevotella 
g: Streptococcus 
g: Veillonella 
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Figure 11: Taxa summary of the genus level for Diabetic versus Normal with most abundant 
genera  
 
 
6. Comparative relative abundance between various categories 
 The top common 25 bacterial genera were compared for normal weight 
participants, overweight and obese (figure 11). It can be noticed that the genus 
Prevotella is less abundant in normal weight individuals as compared to the 
overweight and obese groups similar to Campylobacter, Leptotrichia, 
Saccharibacteria, Megashaera. On the other  hand,  Granulicatella, Gemella, 
Capnocytophaga, Actinomyces, Bergeyella, Fusobacterium are the higher genera in 
the normal weight group when compared to the overweight and obese groups. Figure 
12 shows the differential representation of the top  25 bacterial genera in the normal 
(non diabetic) group and diabetic groups. 
 Diabetic Normal 
g__Prevotella 36.5% 41.5% 
g__Porphyromonas 8.7% 8.4% 
g__Streptococcus 15.0% 13.0% 
g__Veillonella 12.5% 11.1% 
g: Prevotella 
g: Porphyromonas 
g: Streptococcus 
g: Veillonella 
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Figure 12: Hierarchical clustering heatmap of top 25 genera between Normal, Overweight and 
Obese group. Heat map generated using the relative abundance (percent) of top 25 abundant 
bacterial genera. The heat map was generated using the gplots package in R by clustering of 
diabetic and normal group relative abundance of bacterial genera. The heat map scale displays 
the row Z score (Z score = [actual relative abundances of a genus in relevant group − mean 
relative abundance of the same genus in the relevant group]/standard deviation) 
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Figure 13: Hierarchical clustering heatmap of top 25 genera between diabetic and normal group. 
Heat map generated using the relative abundance (percent) of top 25 abundant bacterial genera. 
The heat map was generated using the gplots package in R by clustering of diabetic and normal 
group relative abundance of bacterial genera. The heat map scale displays the row Z score (Z 
score = [actual relative abundances of a genus in relevant group − mean relative abundance of 
the same genus in the relevant group]/standard deviation) 
 
 
7. Interindividual and intraindividual variability: Alpha and beta-diversity 
 Microbiome measurements can be used as indicators of health and disease 
especially when performing a case-control study (J. K. Goodrich et al., 2014). Also, 
it can be an indicator of prognosis by conduction of longitudinal studies (Fukuyama 
et al., 2017) An alpha diversity measure refers to the mean species diversity or species 
richness in a given ecosystem or sample while a beta diversity score identifies whether 
two samples or communities are similar or not (Wagner et al., 2018). Interindividual 
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variability was assessed using measurement of the alpha diversity for each sample. 
Chao1 analysis was used to compare the alpha diversity between normal and diabetic 
group. (Figure 11) shows that the diabetic samples are less diverse than the normal. 
Also, when the BMI categories are compared (Figure 12) the normal weight has a 
greater diversity than the obese and overweight groups. 
 
 
 
 
Figure 14: Alpha diversity of diabetic and normal (non-diabetic) subjects 
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Figure 15: Chao1 analysis for alpha diversity of BMI categories 
 
 
Beta diversity were also calculated, and the results were visualized using Principle of 
Coordinate Analysis (PCoA) by applying weighted UniFrac in which the similarities 
among samples can be illustrated. When Beta diversity was compared among the BMI 
categories, it did not show any form clustering according to the sample category, 
Figure 15. The same was noticed when diabetic group was compared to normal, 
Figure 16. 
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Figure 16: Principle of Coordinate Analysis (PCoA) by applying weighted UniFrac of BMI 
category; red triangle: normal, blue: obese, circle: overweight 
 
 
 
 
Figure 17: Principle of Coordinate Analysis (PCoA) by applying weighted UniFrac of 
diabetic and normal; blue: normal, red: diabetic 
 
 
8. Correlation between clinical variables and microbial data: HALLA 
 Hierarchical All-against-All significance testing or abbreviated HAllA 
considers two data sets and tries to find positive and negative correlation between 
them. In this case, we considered the clinical parameters of all and each group in 
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relation to their microbial composition. When all the participants’ data were tested, 
the genus Catonella and the genus Peptostreptococcus were positively correlated with 
parameters related to hypertension (Figure 17).  
 
 
 
 
Figure 18: Associations between clinical parameters and  microbial composition (genus level) 
for all participants 
 
 
Figure 18 shows that the genera Rothia, Lautropia, Corynebacterium, 
Pseudopropionibacterium are positively correlated with parameters related to glucose 
such as glucose level and HbA1C. 
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Figure 19: Associations between clinical parameters and microbial composition (genus level) 
for the  Diabetic group 
 
 
 The association between participants group according to their BMI and 
microbial composition were tested. We found that Pseudopropionibacterium is 
positively correlated with glucose level in normal weight participants (Figure 19)., 
while the genus Peptostreptococcacea is positively correlated with the insulin level 
in obese group (Figure 20). The genera Capnocytophaga, Fusobacterium, 
Butyrivibrio, Pseudopropionibacterium, and Lautropia were positively correlated 
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with parameters related to blood glucose in overweight group in Figure 21. 
 
 
Figure 20: Associations between clinical parameters and microbial composition (genus level) 
for the normal weight group 
 
 
 
 
Figure 21: Associations between clinical parameters and microbial composition (genus level) 
for the obese group 
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Figure 22: Associations between clinical parameters and microbial composition (genus Level) 
for Overweight group 
 
 
9. Significant differences among clinical categories using LDA (Linear 
discriminant analysis) Effect Size (LEfSe) 
 In order to assess what microbial changes are statistically significant, we ran the 
LefSe analysis. The microbial composition of the BMI groups which include normal, 
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overweight and obese where checked. When comparing the three groups, we 
identified the genus Catonella as the most significantly associated with obesity 
(Figure 22). While when the normal weight group was compared to the overweight 
group, Mogibacterium and Solobacterium were significantly correlated with the BMI 
increase in addition to Catonella (Figure 22). Moreover, when the microbial 
composition of diabetic versus normal was compared, there was no significant genera 
associated with either conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Predictive functional profiling of microbial communities using PiCrust 
 Predictive functional microbial profiles of each taxa were studied against each 
subject category. We found that the N-glycan biosynthesis is highly associated with 
 
Figure 23: LefSe analysis of BMI groups and their microbial composition 
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diabetes and obesity (Figure 23 and 24). There was also not any other significant 
predictive functional profile associated with obesity specifically. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: PiCrust analysis of Normal and diabetic in relation to N-glycan biosynthesis 
(significant difference was observed, p value <0.05) 
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Figure 25: PiCrust analysis of normal weight and obese in relation to N-glycan biosynthesis 
(significant difference was observed, p value <0.05) 
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CHAPTER 5: DISCUSSION 
 
 The salivary microbiome can be a promising diagnostic biomarker as well as a 
forensic marker since the sample is easy to collect and the saliva contents are relatively 
stable. We observed that each individual saliva sample possesses a specific microbial 
signature. Through measurements of alpha and beta diversity, we were able to find 
the interindividual diversity within each sample and between all the samples tested as 
well. We found common shared phyla which resembles Bacteroidetes, Firmicutes and 
Proteobacteria respectively. 
 Although the salivary microbiome of many population remained unexamined, 
there are many studies that support the existence of differences in the microbial 
composition based on the ethnicity (Gupta, Paul, & Dutta, 2017). 
 When we examined the alpha diversity, samples from the diabetic subjects were 
less diverse than the non-diabetic subjects. In addition, when the BMI categories were 
compared, saliva samples from the normal weight subjects showed a greater microbial 
diversity as compared to the obese and overweight groups. A study conducted by 
(Lambeth et al., 2015) to examine the gut microbiome of prediabetic and diabetic 
microbiome composition did not find any relatedness between diversity and HbA1C 
level which may be due to their small sample size. Similar findings from another study 
that compared the alpha diversity between healthy controls, obese and diabetic 
individuals did not find any significant differences in the alpha diversity between the 
three groups (Janem et al., 2017).  In contrast, a  recent study examined the  salivary 
microbiome of diabetic and non-diabetic subjects and stratified the samples according 
to their periodontal health (Sabharwal et al., 2019). In this study, the authors found 
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that  in the diabetic group, microbial alpha diversity was decreased in association with  
periodontal disease.  
 We considered HAllA analysis to find association between clinical parameters 
and microbial composition. We found that the genus Catonella and the genus 
Peptostreptococcus were positively correlated with parameters related to 
hypertension. Moreover, the genera Rothia, Lautropia, Corynobacterium, 
Pseudopropinibactrium are positively correlated with parameters related to glucose 
such as glucose level and HbA1C. 
 In this study, we also investigated the effect of BMI in relation to the microbial 
composition, we show that in the normal weight group, a balanced abundance of 
Bacteroidetes and Firmicutes was observed, whereas, in the overweight and obese 
subjects,  Bacteroidetes were almost double the abundance of Firmicutes. A study on 
a chinese population investigated the salivary microbiome composition in obese 
subjects and found  significant differences between the obese group and normal 
weight group at a more specific taxonomic levels, mainly Haemophilus and 
Cardiobacterium were more abundant in  normal weight group, while Prevotella were 
more abundant in  the obese group (Y. Wu et al., 2018). When we compared the genus 
level of BMI categories, we found that Prevotella are more abundant in both the 
overweight and obese groups as compared to the normal weight group. Moreover, we 
show that Streptococcus and Porphyromonas were decreased in both the obese group 
and the overweight group. 
 When we tested the BMI categories in relation to microbiome profile using 
significant differences among clinical categories using LDA (Linear discriminant 
analysis) Effect Size  or (LEfSe), we found that the two genera Catonella and 
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Solobacterium are constantly associated with obesity which is consistent with the 
findings of the above mentioned study (Y. Wu et al., 2018). 
 We have also studied the predictive functional profiling of microbial 
communities using PiCrust, in which it had revealed that N-Glycan biosynthesis is 
associated with the diabetic group and obese subjects. N-Glycan biosynthesis is a 
feature  known to be associated with eukaryotes(Dell, Galadari, Sastre, & Hitchen, 
2010). However, it is also shared by some bacterial species such as Campylobacter 
jejuni (Kelly et al., 2006). 
In the case of assessing the diabetes and obesity there were some limitations to this 
study due to the small sample size. Moreover sequencing 16S rRNA has its 
limitations, therefore metagenomic or meta-transcriptomic analyses can further 
extend our knowledge in this regard. 
 Our study is the first to assess the salivary microbiome of the Qatari population. 
We show that the salivary microbiome is highly diverse between subjects and changes 
according to the health status. More in depth analysis is needed to understand how the 
identified microbial signatures described in our study, can contribute to disease. While 
the small sample size is a limiting factor of this study, promising results indicated that 
a specific salivary microbial signature can be detected in overweight or obese 
individuals. While using 16S rRNA sequencing technology is sufficient to assess the 
microbial composition in any body site, a deep understanding of the function of those 
microbes is still needed. Hence, applying more in-depth techniques such as shotgun 
metagenomics, metatranscriptomics, microbial metabolomics will enrich our 
understanding on the role of microbiome in various disease conditions including 
obesity and diabetes. Unfortunately, this was not possible in our study due to limited 
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funds allocated to this project.  
Despite its limitations, this study will pave the way towards the possibility to find 
microbial biomarkers that can later be used to detect certain pathological conditions 
such as diabetes and obesity.  
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